Tepnel's Orchid buy brings it HLA (human leukocyte antigen) and genetic testing
This article was originally published in Clinica
Executive Summary
Tepnel Life Sciences (Manchester, UK) is hoping to complete the acquisition of Orchid Diagnostics (Stamford, Connecticut) within two weeks. The $4.3m deal will bring Tepnel an established business in human leukocyte antigen (HLA) testing for matching bone marrow and organ transplant donors and recipients, and a line of consumables for genetic disease screening.